Average Co-Inventor Count = 7.34
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (62 from 215 patents)
2. Other (2 from 832,912 patents)
3. Amgen Inc. (2 from 1,976 patents)
66 patents:
1. 12497383 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
2. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors
3. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
4. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
5. 12054484 - Substituted tetrahydropyrans as CCR2 modulators
6. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
7. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
8. 11834452 - CXCR7 antagonists
9. 11807609 - Deuterated compounds as immunomodulators
10. 11773091 - 6-5 fused rings as C5a inhibitors
11. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
12. 11608336 - Prodrugs of fused-bicyclic C5aR antagonists
13. 11603356 - Amorphous form of a complement component C5a receptor
14. 11485737 - Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
15. 11479553 - 5-5 fused rings as C5a inhibitors